ESC CONGRESS 2019

31 August - 04 September 2019, Paris - France

Session Details

Poster Session 4: Issues surrounding aortic valves interventions
Mon 02 Sep 08:30 - 12:30 European Society of Cardiology Poster Session, Abstract-based Programme Posters - Poster Area
Learning Objectives: Posters are on display from 08:30 – 12:30. Presenters will be by their poster during the coffee break from 10:05 and 10:55 for posters viewing time.

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:30P3692Funding resistance and 1-year outcomes in SHARE-TAVI, a local South African TAVR/TAVI registryElizabeth SCHAAFSMA (Johannesburg, South Africa)
08:30P3693Self-expandable transcatheter aortic valve implantation is associated with frequent periprocedural stroke detected by diffusion-weighted magnetic resonance imaging -Insight from propensity score matchMana OGAWA (Osaka, Japan)
08:30P3694Discordant criteria in moderate aortic stenosis patients: prognostic implicationsStephan Milhorini PIO (Leiden, Netherlands (The))
08:30P3695Predicting adverse outcomes after TAVI procedure - a comparison of two CoreValve generations using real-life outcomes and patient-specific computer simulations Filip LONCARIC (Barcelona, Spain)
08:30P3696Correlates of the ratio of acceleration time to ejection time in patients with aortic stenosis: an echocardiographic and computed tomography study Alexandre ALTES (Lille, France)
08:30P3697A reappraisal of bioprosthetic aortic valve failure related to structural valve degenerationThierry LE TOURNEAU (Nantes, France)
08:30P3698Long-term durability of transcatheter aortic valve prostheses: results of a center.Antonio Jesus MUNOZ GARCIA (Madrid, Spain)
08:30P3699Circulating pro-apoptotic microRNA-122 correlates with left ventricular function (LVEF) improvement after transcatheter aortic valve replacement and influence cardiomyocyte function via microvesicleXiang XU (Bonn, Germany)
08:30P3700Left trial appendage thrombosis in patients with severe aortic stenosis treated by transfemoral transcatheter aortic valve implantationNorman MANGNER (Dresden, Germany)
08:30P3701Short-term decrease of left atrial size predicts clinical outcome in patients with severe aortic stenosis undergoing transcatheter aortic valve replacementRoberta DE ROSA (Salerno, Italy)
08:30P3702Aortic stenosis and inappropriate myocardial hypertrophy: is there a difference related to gender?Vitor EMER EGYPTO ROSA (Sao Paulo, Brazil)